ROCKFISH BIO
DEAD

Serial Number

79421383

Owner

Rockfish Bio AG

Filing Date

Feb 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ROCKFISH BIO Trademark

Serial Number: 79421383

ROCKFISH BIO is a trademark filed by Rockfish Bio AG on February 17, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Rockfish Bio AG

Reichsratsstrasse 15/15

Entity Type: 25

Trademark Details

Filing Date

February 17, 2025

Registration Date

Not Registered

Goods & Services

Human healthcare services; medical and healthcare services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment of patients; medical testing services relating to the diagnoses and treatment of diseases; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; provision of medical treatment for prophylaxis or therapy; medical and healthcare services in the field of personalized medicine; services of personalized medical treatment for prevention of chronic diseases, age-related disorders and diseases and neurodegenerative disorders and diseases; information consultancy and advisory services in relation to the aforesaid.

Scientific research and development; scientific research and development in the fields of senolytics, age-related disorders and diseases and neurodegenerative disorders and diseases therapies; services related to scientific research, development and production of pharmaceutical and biopharmaceutical agents and preparations; services in the field of research, development and production of medical, pharmaceutical and biopharmaceutical products; medical- and pharmacological research services; pharmaceutical, biopharmaceutical drug development services; drug discovery services; providing medical and scientific research information in the field of clinical trials.

Assays and reagents for scientific and research use; diagnostic reagents for scientific use; senolytics

Reagents and assays for medical or veterinary use; pharmaceuticals; pharmaceuticals for the treatment and prevention of chronic diseases; pharmaceuticals for the treatment and prevention of age-related disorders and diseases and neurodegenerative disorders and diseases; pharmaceuticals for healthy ageing; pharmaceuticals for the treatment and prevention of disorders and diseases linked to senescent cell accumulation.

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 13, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 13, 2026 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
REFUSAL PROCESSED BY IB
Sep 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 28, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 28, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 24, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 23, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 10, 2025 REPR